The European College of Neuropsychopharmacology (ECNP) established by clinicians and scientists of neuropsychopharmacology and its related areas in 1987 is a non-profitable scientific organisation whose goal is to take up experiments that would promote ways for improving patient care regarding mental disorders.

Next to the establishment of first ECNP School of Neuropsychopharmacology on 5th July 2009, a scientific conference is to be held from 12th September 2009 at Istanbul in which nearly 600 experts from 25 countries is to discuss over 100 topics like neuroscience and psychopharmacology, schizophrenia, ADHD , Alzheimer's disease vaccination, NewMood project news etc. Ample amount of focusing is done to give crystal clear ideas for medical professionals that would ease their clinical practice.

The ECNP congress comprises of educational update sessions dealing with insomnia treatment, ICD-11 and DSM-V classification systems, neuropsychopharmacology biomarkers,GABA etc and 3 poster sections where nearly 900 posters are being presented by scientists from worldwide.In addition to these ECNP proudly presents Consultation Meeting 2009's report on "Biomarkers and experimental medicine in developing new treatments in neuropsychopharmacology". Scientists, pharmaceutical industry and the regulatory authorities discuss and exchange their views and advices through the consultation meetings held annually by the ECNP on specific topics.